Back

Routine Ankle-Brachial Index (ABI) measurement: a window into atherosclerosis and early left ventricular dysfunction in patients diagnosed with cancer

11 May 2024 (13:00 - 14:00)
Organised by: Logo
Congress Presentation Part of: ePosters in Cardiovascular disease in special populations (1) Cardio-Oncology HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Moaad Slieman

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)

6 More presentations in this session

Presentation thumbnail
Long-term cardiovascular outcomes after severe burn injury
Ms V. Krbcova Moudra (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of 18F-fluorodeoxyglucose positron emission tomography and 67gallium scintigraphy in cardiac sarcoidosis.
Doctor Y. Takigami (Sagamihara, JP)
Abstract Slides Video
Presentation thumbnail
Impact of cardiovascular disease burden on the severity of COVID-19 patients
Doctor D. De Almeida Fernandes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Cancer therapy-related cardiovascular toxicity: what is the accuracy of baseline cardiovascular risk stratification in the prediction of its occurrence?
Doctor N. Cotrim (Santarem, PT)
Abstract Slides Video
Presentation thumbnail
Morbidity and mortality of cardio-oncology patients: is there any link to baseline cardiovascular risk?
Doctor B. Andrade (Santarem, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in Cardiovascular disease in special populations (1)

The Event

Event poster

Heart Failure 2024

11 May 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Ankle brachial index,a non invasive tool predicts cardiovascular events after acute myocardial infarction:a 3 year follow -up study
thumbnail
Congress Presentation
Surveillance of left ventricular function among asymptomatic cancer survivors
thumbnail
Congress Presentation
The predictors of clinical outcome in the patients undergoing endovascular intervention for lower extremity peripheral arterial disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources